The pharmaceutical industry market of Mordovia contributes to ensuring the national drug security

Russia steadily continues to strengthen its medicinal sovereignty. The Prime Minister Mikhail Mishustin was talking about that at the strategic session on the results of the work of deputy prime ministers as curators of federal districts.

Currently, 357 important initiatives are being implemented in the regions. These initiatives include the creation of pharmaceutical substances and medicines in Mordovia, at the Biokhimik plant, which is the Promomed Group’s production site.

Providing the population with vital medicines is one of the main tasks that our company is working on. Using high technologies in production and developing innovative solutions to critical medical challenges, Promomed Group helps to ensure the drug security of Russia.

The Biokhimik plant has one of the largest production facilities of active pharmaceutical substances in Russia. New drugs are created in a full cycle – from molecule to finished dosage form. Most of them belong to vital drugs in the treatment of cancer, viral diseases, in endocrinology and neurology.